Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126542
Status:
COMPLETED
Last Update Posted:
2014-05-14
First Post:
2005-08-02
Brief Title:
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial Fallopian Tube or Primary Peritoneal Cavity Cancer
Sponsor:
Organization:
National Cancer Institute NCI